World · en
Japan stem cell heart disease patch gets insurance approval
TOKYO -- An induced pluripotent stem (iPS) cell treatment for heart disease became eligible for Japan's public health insurance coverage on Tuesday, m
Related index pages
Business · BBC NewsJapan Inc is betting big on India as China risks deepen
Japanese companies are doubling down on India amid a shrinking domestic market and rising risks in China.Read original ↗
Technology · WIREDYou Know Who Really Hates AI? Insurance Claims Adjusters
Of the Glassdoor reviews from claims adjusters that mentioned AI, a staggering 98 percent were negative. “AI is just a tool,” one person tells WIRED.…Read original ↗
Society · NPRWhat Argentina gets right about youth soccer — and what the U.S. gets wrong
Argentina has produced some of the world's greatest soccer players. Could its youth system offer lessons for the United States?Read original ↗
Business · Nikkei AsiaAs bonds sell off, Japan needs the discipline of high interest rates
TOKYO -- With Japan's long-term bond yields climbing above 3% for the first time in 30 years, interest rates may better fulfill one of their most basiRead original ↗
Business · Nikkei AsiaJapan benchmark bond yield hits 30-year high of 3% amid global debt selloff
TOKYO -- The yield on benchmark 10-year Japanese government bonds briefly reached 3% on Tuesday, hitting a three-decade high as a global sell-off in sRead original ↗
Business · Nikkei Asia